1Clinical and Laboratory Standards Institute. Performance Standards for Antimicrobial Susceptibility TestingTwen- ty-Second Informational Supplement. CLSI document M100-$22 [S]. Wayne, PA, USA: CLSI, 2012.
2Editorial Office of Weekly Epidewiol Rec. Pneumococcal con jugate vaccine for childhood immunizationWHO position paper[J]. Weekly Epidemiol Rec, 2007,82 (12) :93-104.
3Centers for Disease Control and Prevention(CDC). Effects of new penicillin susceptibility breakpoints for Streptococcus pneumoniae-United States, 2006-2007 [J]. MMWR, 2008, 57(50) ..1353-1355.
4Clinical and I.aboratory Standards Institute. Performance Standards for Antimicrobial Susceptibility Testing Eight- een Informational Supplement. CLSI document M100-S18 [S]. Wayne, PA, USA.. CLSI, 2008.
5Dogan O, Gulmez D, Hascelik G. Effect of new break points proposed by Clinical and Laboratory Standards In- stitute in 2008 for evaluating penicillin resistance of Streptococcus pneumoniae in a Turkish University Hos- pital[J]. Microb Drug Resist,2010,16(1)..39-41.
